Evommune closes $115M Series C Funding

← Back to News
Previous
Previous

Alyssum Therapeutics closes $28M in Series A Funding

Next
Next

Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health